Remove Demo Remove Marketing Remove Pharmaceuticals
article thumbnail

Episode 17: The Transformative CL&D Strategies Journey with Todd Amrhein

ACTO

Todd Amrhein Award-winning Director of Global Training, Learning and Development, Marketing, and Sales About Todd Amrhein : Todd is a results-driven, award-winning Director of Global Training, Learning and Development, Marketing, and Sales in the biotechnology and pharmaceutical industry.

article thumbnail

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

H1 Blog

This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.

FDA 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Payer Trends Can Tell Us About Medication Adherence

H1 Blog

Strategies for Market Access Teams One thing the healthcare ecosystem lacks in the United States is a system of shareable, actionable healthcare data. How do pharmaceutical companies work with payers? For more information about understanding payer and patient utilization trends, request a demo. The answer is payers and claims.

article thumbnail

H1’s Predictions for Healthcare and Pharma in 2025

H1 Blog

Drug Pricing, Global Diversity Strategies, & Emerging AI Applications Each year, we compile our predictions to provide life sciences, pharmaceutical, and healthcare organizations with a comprehensive look at emerging industry trends and dynamics to help them prepare for the year ahead.

article thumbnail

Building an Exclusive Strategy with Inclusive HCPs

H1 Blog

Trusted Advisors for Scientific Exchange As pharmaceuticals strive to create medications that are more effective and accessible, it’s essential that they engage HCPs early in order to understand the needs of their target audiences.

article thumbnail

Optimizing Clinical Data Registries: Opportunities for Diversity and Feasibility

H1 Blog

Every day, patients around the globe are waiting for life-saving treatments to reach the market. However, despite these commitments, recent investigations indicate significant scope for improvements in data sharing by the pharmaceutical industry.

article thumbnail

The Trust Fall: Building Successful & Diverse Trials Outside the U.S.

H1 Blog

Predictive analytics has been gaining traction as a powerful tool in pharmaceuticals and biotechnology over the past few years, but its potential has yet to be fully realized when it comes to international clinical trials. Request a demo of Trial Landscape.

Trials 59